Rho’s Rob Woolson and Derek Lawrence will discuss in an upcoming webinar how the company is helping trial sponsors get the most out of decentralized trials.
Woolson is Rho’s chief strategist of biostatistics and standards for regulatory submissions, and Derek Lawrence is the associate director of data management.
“Hybrid, Virtual, and Synthetic clinical trials are becoming a part of an increasing number of drug and biologics development programs,” a description states. “In this webinar, Rho experts discuss how their approach to maximizing the benefits of decentralized trials helps sponsors get the most out of their trials … .”
For additional information and registration details, click here.